Donate placenta after C-section for mitochondrial research and future therapies
Part of Women’s health & pregnancy clinical trials.
This study collects donated placenta after a planned C-section to isolate mitochondria (the cell’s energy parts) for research and possible future therapies. Participation mainly involves being a medically healthy pregnant person who meets specific health and medication safety checks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18–45 years old and considered medically eligible by the study doctors
- You are planning an elective C-section around weeks 36–41 of pregnancy
- Your pregnancy is uncomplicated, as the study doctor confirms
- You must have your medical history available (diagnoses, illnesses, and medications)
- You (as the donor) must not test positive or be considered at risk for certain infections
- You must avoid certain medications close to donation and meet other health limits (e.g., smoking/alcohol, diabetes, cancer)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the placenta is working in pregnancies that are planned for cesarean delivery after at least 37 weeks. Researchers compare different pregnancy situations (including some common complications) and check placenta function to better understand placental health.
This study builds a repository (a database of samples and health information) from pregnant people to better understand and improve how we care for placenta-related conditions. By joining, you help researchers learn more about both high-risk and typical pregnancies, which could lead to better care for future families.
This study looks at gene activity in the placenta during early and full-term pregnancy. It may help researchers understand how the placenta works and how it affects both mother and baby.
This study collects blood and skin samples from people with primary mitochondrial disease and from healthy volunteers. The samples will help researchers better understand these diseases and develop future treatments.
This study follows families using mitochondrial donation to reduce the risk from a confirmed mitochondrial DNA (mtDNA) mutation. It aims to learn outcomes over about 18 months of the child’s life and whether the treatment works well and safely for families like yours.
This study collects placenta tissue (or tissue from an abortion) from women at the Grenoble University Hospital to better understand pregnancy problems linked to the placenta. By participating, you help researchers learn more about conditions that affect pregnant women and their babies.
Hear when a new Pregnancy Related trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.